Sorry, Your Requested Page Was Not Found.
Greetings! We apologize for the inconvenience, but the page, World News Story In Surprise Decision Us Approves Muscular Dystrophy Drug is no longer available. Please use our search box below to find related content and browse the list of related news stories. Depending on the topic, news articles are deleted 3 - 18 months after the created date. We prefer to keep content fresh and current and not keep old news. Thanks for visiting today.Search RobinsPost News & Noticias
UPDATE 2-US FDA approves Italfarmaco's drug for Duchenne muscle-wasting disorder
March 21 (Reuters) - The U.S. FDA has approved privately held Italfarmaco Group's drug to treat Duchenne muscular dystrophy (DMD ... Bettica said ahead of the decision. "When you give givinostat ... Read More
Italfarmaco secures FDA approval for Duchenne muscular dystrophy drug
Italy-based pharma company Italfarmaco has secured approval from the US Food and Drug Administration (FDA) for its Duchenne muscular dystrophy ... making it one of the world’s most expensive ... Read More
FDA asks for more data on Sarepta's muscular dystrophy drug
There has been much speculation about whether the US regulator will finally approve Sarepta Therapeutics' eteplirsen for Duchenne muscular dystrophy ... Drug Administration would delay a decision ... Read More
FDA approves Italfarmaco’s Duvyzat as first nonsteroidal Duchenne muscular dystrophy drug
The US Food and Drug Administration (FDA) has approved Italfarmaco’s Duvyzat (givinostat) as the first nonsteroidal drug to treat patients with all genetic variants of Duchenne muscular dystrophy ... Read More
Novel Drug Approved for All Duchenne Muscular Dystrophy Variants
Opens in a new tab or window The FDA approved oral givinostat (Duvyzat) to treat Duchenne muscular dystrophy (DMD ... It's the first nonsteroidal drug approved for patients with all genetic ... Read More
US FDA approves Italfarmaco's drug for Duchenne muscle-wasting disorder
(Reuters) - The U.S. FDA has approved privately held Italfarmaco Group's drug to treat Duchenne muscular dystrophy (DMD ... Paolo Bettica said ahead of the decision. Read More
FDA asks for more data on Sarepta's muscular dystrophy drug
There has been much speculation about whether the US regulator will finally approve Sarepta Therapeutics' eteplirsen for Duchenne muscular dystrophy ... Drug Administration would delay a decision ... Read More
US FDA approves Italfarmaco's drug for Duchenne muscle-wasting disorder
March 21 (Reuters) - The U.S. FDA has approved privately held Italfarmaco Group's drug to treat Duchenne muscular dystrophy ... the news and media division of Thomson Reuters, is the world ... Read More
Blow Us A Whistle
Comments (Whistles) Designed By Disqus